These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 33264412)

  • 1. ACE2 in the renin-angiotensin system.
    Verano-Braga T; Martins ALV; Motta-Santos D; Campagnole-Santos MJ; Santos RAS
    Clin Sci (Lond); 2020 Dec; 134(23):3063-3078. PubMed ID: 33264412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme 2: a key enzyme in key organs.
    Pagliaro P; Thairi C; Alloatti G; Penna C
    J Cardiovasc Med (Hagerstown); 2022 Jan; 23(1):1-11. PubMed ID: 34091532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
    Shukla AK; Banerjee M
    High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alamandine: Potential Protective Effects in SARS-CoV-2 Patients.
    Soltani Hekmat A; Javanmardi K
    J Renin Angiotensin Aldosterone Syst; 2021; 2021():6824259. PubMed ID: 34853605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.
    Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F
    Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology.
    Vieira C; Nery L; Martins L; Jabour L; Dias R; Simões E Silva AC
    Curr Drug Targets; 2021; 22(3):254-281. PubMed ID: 33081670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE2: from protection of liver disease to propagation of COVID-19.
    Warner FJ; Rajapaksha H; Shackel N; Herath CB
    Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II receptors: Impact for COVID-19 severity.
    Aksoy H; Karadag AS; Wollina U
    Dermatol Ther; 2020 Nov; 33(6):e13989. PubMed ID: 32645228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists.
    Steckelings UM; Sumners C
    Clin Sci (Lond); 2020 Nov; 134(22):2987-3006. PubMed ID: 33210709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor.
    Oz M; Lorke DE; Kabbani N
    Pharmacol Ther; 2021 May; 221():107750. PubMed ID: 33275999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foe and friend in the COVID-19-associated acute kidney injury: an insight on intrarenal renin-angiotensin system.
    Xu C; Chen Y; Yu J
    Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(1):1-11. PubMed ID: 35130610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatment.
    Lumbers ER; Head R; Smith GR; Delforce SJ; Jarrott B; H Martin J; Pringle KG
    Pharmacol Res Perspect; 2022 Feb; 10(1):e00917. PubMed ID: 35106954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the Molecular Impact of SARS-CoV-2 Infection on the Renin-Angiotensin System.
    Pucci F; Bogaerts P; Rooman M
    Viruses; 2020 Nov; 12(12):. PubMed ID: 33265982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-angiotensin system at the interface of COVID-19 infection.
    Gul R; Kim UH; Alfadda AA
    Eur J Pharmacol; 2021 Jan; 890():173656. PubMed ID: 33086029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019.
    Suh SH; Ma SK; Kim SW; Bae EH
    Korean J Intern Med; 2021 Mar; 36(2):247-262. PubMed ID: 33617712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment.
    Chappell MC
    Circ Res; 2023 May; 132(10):1320-1337. PubMed ID: 37167353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and characterization of ACE2 - a 20-year journey of surprises from vasopeptidase to COVID-19.
    Hooper NM; Lambert DW; Turner AJ
    Clin Sci (Lond); 2020 Sep; 134(18):2489-2501. PubMed ID: 32990314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Acetyl-Seryl-Asparyl-Lysyl-Proline regulates lung renin angiotensin system to inhibit epithelial-mesenchymal transition in silicotic mice.
    Li S; Li Y; Zhang Y; Li S; Zhang M; Jin F; Wei Z; Yang Y; Gao X; Mao N; Ge X; Xu H; Yang F
    Toxicol Appl Pharmacol; 2020 Dec; 408():115255. PubMed ID: 33007385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
    Tseng YH; Yang RC; Lu TS
    Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19.
    Pedrosa MA; Valenzuela R; Garrido-Gil P; Labandeira CM; Navarro G; Franco R; Labandeira-Garcia JL; Rodriguez-Perez AI
    Clin Sci (Lond); 2021 Feb; 135(3):465-481. PubMed ID: 33479758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.